Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

PTC Therapeutics initiates phase IIb clinical trial of PTC-124 in DMD/BMD

April 28, 2008

Amkor completes its phase I study of NEU-2000 in brain injury

April 28, 2008

Recent patents describe novel therapeutic agents for neurological disorders

April 25, 2008

CHMP issues positive opinion for Neupro for restless legs syndrome

April 25, 2008

Alpharma to withdraw and resubmit NDA to the FDA for Embeda

April 25, 2008

New anxiolytic and antidepressant agents disclosed in recent patent literature

April 25, 2008

Sygnis receives E.U. orphan drug designation for AX-200 in ALS

April 25, 2008

FDA approves Vyvanse to treat adult ADHD

April 25, 2008

Novel agents for neurological disorders described in recent AstraZeneca and Merck Frosst patents

April 24, 2008

Dainippon Sumitomo Pharma launches Lonasen for schizophrenia

April 24, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...